Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Kincell Bio, a CDMO focused on cell therapies, received $36 million in new funding. Kineticos Ventures led Kincell’s launch funding.
read more
Wednesday, February 11, 2026
Kincell Bio announced a new collaboration with RegCell. Under the partnership, Kincell Bio will provide comprehensive CMC development and GMP manufacturing support to accelerate RegCell’s lead Treg program toward clinical trial evaluation.
read more
Kincell Bio announced a significant strategic investment to expand and strengthen its Research Triangle Park (RTP), North Carolina facility. The expansion reinforces Kincell Bio's commitment to supporting clients as they advance from late-stage ...
read more
Wednesday, April 25, 2018
KinderPharm and Worldwide Clinical Trials have entered into a strategic alliance to deliver the world’s first single center of excellence for pediatric drug development and clinical research for the pharmaceutical industry.
read more
Kindeva announced the appointment of Melanie Cerullo as Chief Quality Officer to drive its quality, compliance and regulatory strategy.
read more
Friday, December 16, 2022
Kindeva Drug Delivery and Meridian Medical Technologies announced the completion of the transaction to combine the two companies
read more
Thursday, January 15, 2026
Kindeva announced a series of planned leadership transitions designed to position the company for accelerating growth in its core businesses focused on parenteral and inhaled drug delivery.
read more
Kindeva announced the promotion of David Stevens, Chief Operating and Commercial Officer, to the newly created role of President. In this capacity, David will lead Kindeva’s global operations.
read more
Kindeva has appointed Daniel J. Speciale as Chief Financial Officer (CFO) to strengthen its executive leadership team and drive financial strategy across the organization.
read more
Thursday, January 09, 2025
Kindeva Drug Delivery and Emervax announced an exclusive partnership to co-develop a solution for the administration of vaccines targeting a variety of emerging viruses.
read more
Wednesday, April 10, 2024
Syntegon announced the sale of its newly developed Versynta microBatch production cell to its first U.S. customer. Kindeva Drug Delivery will use Versynta microBatch to further expand its suite of aseptic fill-finish contract development and ...
read more
Monday, September 18, 2023
Kindeva Drug Delivery, a global drug delivery device contract development and manufacturing organization (CDMO), announced that Brian Schubmehl has joined the company as Chief Human Resources Officer.
read more
Tuesday, January 21, 2025
Kindeva Drug Delivery's global health security division, Meridian Medical Technologies, LLC, secured a contract valued at up to $129 million to supply DuoDote®, a chemical nerve agent antidote autoinjector, to the Strategic National Stockpile (SNS), ...
read more
Wednesday, October 09, 2024
Kindeva Drug Delivery announced two key milestones for its state-of-the-art Bridgeton, MO, facility. The site has successfully completed its first registration batch on its groninger high-volume vial line.
read more
Thursday, January 18, 2024
In a strategic move, Kindeva Drug Delivery has successfully acquired Summit Biosciences Inc., a prominent contract development and manufacturing organization (CDMO) specializing in intranasal drug delivery.
read more